Alimera Sciences Profile

1.41
USD 0.03  2.17%
1.34Last Month High 1.42 
1.38Trading Day  High 1.46 

Purchase by Flynn James E of 71540 shares of Alimera Sciences

Alimera Sciences Inc insider trading alert for perchase of common stock by Flynn James E, the corporate stakeholder, on October 2, 2017. This event was filed by Alimera Sciences Inc with SEC on 2015-10-09. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Alimera Sciences Summary

Alimera Sciences Inc (ALIM) is traded on NASDAQ General Markets in USA. It is located in GEORGIA, U.S.A and employs 125 people. Alimera Sciences is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 97.36 M. Alimera Sciences Inc has 69.05 M outstanding shares of which 617.09 K shares are presently shorted by private and institutional investors with about 1.77 trading days to cover. Alimera Sciences currently holds about 26.88 M in cash with (17.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39.
Check Alimera Sciences Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Livingston Group Asset Management Co Operating As Southport Capital ManagementCommon Shares33.4 K45 K
Armistice Capital Llc 0Common Shares5.9 M8.2 M
View Alimera Sciences Diagnostics

Selected Alimera Sciences Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Alimera Sciences Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 84% 
Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, Portugal, and the United Kingdom. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAlimera Sciences Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationGEORGIA, U.S.A
Business Address6120 Windward Parkway, Suite 290, Alpharetta, GA 30005, United States
ExchangeNASDAQ General Markets
CIK Number01267602.0
CUSIP016259103
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.alimerasciences.com
Contact Number678 990 5740
CurrencyUSD - US Dollar

Recommendations

Alimera Sciences Analyst Recommendations
Target PriceAdvice# of Analysts
3.0Strong Buy1Odds
Alimera Sciences Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Alimera Sciences Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Alimera Sciences Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.05March 1, 2017
Alimera Sciences Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate